Join the Pain group to help and get support from people like you.
Pain News
'Drug Take Back Day' is Saturday: Check for Leftover Opioids in Your Home
FRIDAY, April 26, 2024 – Each year, thousands of Americans head home after a surgery clutching prescription opioids to help ease post-surgical pain. Trouble is, most won't use all those pills, and...
Self-Administered Acupressure Reduces Knee Pain With Suspected Osteoarthritis
WEDNESDAY, April 24, 2024 – Self-administered acupressure (SAA) is an efficacious and cost-effective approach to relieve knee pain in middle-aged and older adults with probable knee osteoarthritis...
Immersive Virtual Reality Beneficial for Pain Relief in Cancer
MONDAY, April 8, 2024 – For hospitalized patients with cancer, immersive virtual reality (VR) distraction therapy is associated with a greater reduction in pain compared with an active control,...
Stepped Collaborative Intervention Improves Quality of Life in Cancer
THURSDAY, March 28, 2024 – A stepped collaborative care intervention can improve health-related quality of life for patients with cancer and depression, pain, or fatigue, according to a study...
FDA Medwatch Alert: FDA Warns Consumers to Avoid Certain Topical Pain Relief Products Due to Potential for Dangerous Health Effects
March 26, 2024 – The U.S. Food and Drug Administration is warning consumers not to use certain over-the-counter analgesic (pain relief) products that are marketed for topical use to relieve pain...
Could Biofeedback Help Ease Long COVID?
MONDAY, March 18, 2024 – Breathing and relaxation techniques may offer relief to some patients battling Long COVID. In a new, small study of 20 patients, biofeedback therapy relieved both the...
Elimination of Extended-Release Opioids Can Improve Outcomes After TKR
MONDAY, March 11, 2024 – Elimination of extended-release (ER) opioids in the multimodal medication regimen of total knee replacement (TKR) patients can improve outcomes, including reducing...
Vertex Announces Statistically Significant and Clinically Meaningful Results From Two Phase 2 Proof-of-Concept Studies of VX-548 for the Treatment of Acute Pain
Treatment with the NaV1.8 inhibitor VX-548 met the primary endpoint in both Phase 2 proof-of-concept acute pain studies following abdominoplasty or bunionectomy surgery VX-548 was generally well...
Vertex Advances VX-548 in Acute and Neuropathic Pain
VX-548 advances into pivotal development for people with acute pain; Phase 3 program to initiate in Q4 2022 Phase 2 dose-ranging trial in neuropathic pain expected to initiate by year end...
Vertex Announces Publication of VX-548 Positive Phase 2, Proof-of-Concept Results in New England Journal of Medicine
First published manuscript of VX-548 preclinical and clinical trial results in a peer-reviewed journal BOSTON--(BUSINESS WIRE)--Aug. 3, 2023-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX)...
Vertex Announces Positive Results From the VX-548 Phase 3 Program for the Treatment of Moderate-to-Severe Acute Pain
BOSTON--Jan. 30, 2024-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced positive results from its Phase 3 program for the selective NaV1.8 inhibitor, VX-548, in the treatment of...
New Insights Into the Persistent Pain of UTIs
MONDAY, March 4, 2024 – People with recurring urinary tract infections frequently have persistent pain, even after antibiotics have cleared the harmful bacteria from their system. Now, researchers...
Factors Identified for Integrative Health and Medicine Use in Chronic Pain
MONDAY, Feb. 12, 2024 – Factors associated with engagement in integrative health and medicine (IHM) and nonpharmacologic modalities versus opioids have been identified for adults with chronic pain,...
Relationship Between Exercise, Pain Not Modified by Cancer History
MONDAY, Feb. 12, 2024 – The relationship between physical activity and pain outcomes does not differ for those with or without a history of cancer, and cancer survivors who engage in more physical...
2002 to 2022 Saw Increased Use of Complementary Health by U.S. Adults
WEDNESDAY, Feb. 7, 2024 – Between 2002 and 2022, U.S. adults significantly increased use of complementary health approaches (CHAs), including for pain management, according to a research letter...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Chronic Pain, Back Pain, Fibromyalgia, Headache, Muscle Pain, Neuralgia, Neck Pain, Chronic Myofascial Pain, Nocturnal Leg Cramps, Reflex Sympathetic Dystrophy Syndrome, Breakthrough Pain
Related drug support groups
tramadol, gabapentin, ibuprofen, oxycodone, Tylenol, hydrocodone, naproxen, acetaminophen, meloxicam, view more... amitriptyline, aspirin, Percocet, hydroxyzine, Norco, pregabalin, methadone, duloxetine, diclofenac, OxyContin, Vicodin, codeine, cyclobenzaprine, Aleve, Celebrex, Advil, fentanyl, Voltaren, morphine, clonidine, Paracetamol Teva, nortriptyline, buprenorphine, Butrans, Paracetamol, Dilaudid, Motrin, cannabis, Tylenol PM, Toradol, indomethacin, Lortab, Ultram, Vistaril, acetaminophen / hydrocodone, Roxicodone, ketamine, Arthritis Pain, Atarax, ketorolac, Percocet 10/325, Nucynta, hydromorphone